These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33713386)

  • 1. Differential characteristics and outcomes of Asian and non-Asian patients with HBV-related hepatocellular carcinoma.
    Huang DQ; Hoang JK; Leong J; Riveiro-Barciela M; Maeda M; Yang JD; Accarino EV; Thin K; Trinh L; Cheung RC; Roberts LR; Buti M; Schwartz M; Nguyen MH
    Liver Int; 2021 Aug; 41(8):1922-1932. PubMed ID: 33713386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence.
    Wang W; Tian SL; Wang H; Shao CC; Wang YZ; Li YL
    JAMA Netw Open; 2020 Apr; 3(4):e203707. PubMed ID: 32338753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of Antiviral Therapy for Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Nationwide Real-World US Study.
    Kudaravalli S; Kam LY; Huang DQ; Cheung R; Nguyen MH
    Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3305-3313.e4. PubMed ID: 37805836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
    Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis.
    Tsai MC; Yang SS; Lin CC; Wang WL; Hsu YC; Chen YS; Hu JT; Lin JY; Yu ML; Lin CW
    JAMA Netw Open; 2022 Jul; 5(7):e2223511. PubMed ID: 35877121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC.
    Tian Y; Lyu H; He Y; Kanduri HK
    J Gastrointest Cancer; 2019 Sep; 50(3):400-407. PubMed ID: 29512001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.
    Wong LL; Limm WM; Tsai N; Severino R
    World J Gastroenterol; 2005 Jun; 11(23):3491-7. PubMed ID: 15962361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA.
    Tong MJ; Chavalitdhamrong D; Lu DS; Raman SS; Gomes A; Duffy JP; Hong JC; Busuttil RW
    J Clin Gastroenterol; 2010 Mar; 44(3):e63-70. PubMed ID: 19745756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy.
    Lin CL; Tseng KC; Chen KY; Liao LY; Kao JH
    J Formos Med Assoc; 2020 Oct; 119(10):1483-1489. PubMed ID: 32653388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
    Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.
    Young K; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
    J Viral Hepat; 2017 Sep; 24(9):789-796. PubMed ID: 28273387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
    Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
    BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral hepatitis B and hepatocellular carcinoma.
    Michielsen P; Ho E
    Acta Gastroenterol Belg; 2011 Mar; 74(1):4-8. PubMed ID: 21563647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.
    Yip B; Wantuck JM; Kim LH; Wong RJ; Ahmed A; Garcia G; Nguyen MH
    Dig Dis Sci; 2014 Jan; 59(1):192-200. PubMed ID: 24282055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of HBV DNA load on the safety and prognosis of systematic therapy in advanced hepatocellular carcinoma].
    Zheng XR; Peng JX; Song X; Liu B; Zhong C; Chen XY; Zhang BX; Peng L; Zhu KS; Xie C
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1160-1167. PubMed ID: 38583047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.